CalciMedica, Inc. (CALC)
Last updated: 2026-10-20 21:40:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
CalciMedica, Inc. (CALC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.06, with a market capitalization of $7.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.00 to $36.00. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$7.10M | |
$1.03 | |
$2,807.00 | |
$1.00 | |
$1.02 | |
41.55K | |
75.31K | |
-- | |
$36.00 | |
$1.00 | |
-- | |
-- |
CalciMedica, Inc. (CALC) After-Hours Stock Price
CalciMedica, Inc. (CALC) is trading at $1.06 in after-hours trading as of 2026-10-20 21:07:00, up 3.92% ($0.04) from the regular-session close of $1.02.
After-hours trading shows how investors are pricing CALC after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
CalciMedica, Inc. (CALC) 7-Day Stock Price Change
Over the past seven days, CalciMedica, Inc. (CALC) moved from $1.27 to $1.06, representing a decline of 16.54% ($0.21).
The stock traded between $1.00 and $1.34 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 50.29 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
CALC 52-Week Price Position
Position in Range: 0.2%
CALC is currently trading at $1.06, placing it 0.2% of the way from its 52-week low of $1.00 to its 52-week high of $36.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is CalciMedica, Inc. (CALC)?
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.
CalciMedica, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 15 |
| Exchange | NASDAQ |
| Company Website |
How to Buy CalciMedica, Inc. (CALC) Stock on MEXC
Eligible investors can buy real shares of CalciMedica, Inc. (CALC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is CalciMedica, Inc. (CALC) stock price today?
2.Is CALC stock going up or down today?
3.What is CALC pre-market price?
4.What is CALC after-hours price?
5.Is CALC stock trading now?
6.Where does CALC sit relative to its 52-week high and low?
7.What sector is CalciMedica, Inc. in?
8.What is CalciMedica, Inc.'s market capitalization and where is it listed?
9.How is CALC valued in terms of P/E ratio and EPS?
10.Does CalciMedica, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
CALC Stock Calculator
Estimate the value between CALC shares and USD.
CALC Shares to USD
1.00 CALC shares = 1.06 USD
Calculations are estimates based on the latest available price and are for reference only.


